Yahoo Web Search

Search results

1. wiza.co › d › abbvieRobert Mills - Quality Manager, Product Quality Assurance at ...

   wiza.co › d › abbvie

   • Cached

   View Robert Mills' email address (r*****@abbvi***.com) and phone number. Robert works at Abbvie as Quality Manager, Product Quality Assurance. Robert is based out of Greater Chicago Area and works in the Pharmaceutical Manufacturing industry.

2. Images

   • 
   • 
   • 
   • 

   View all

3. news.abbvie.com › 2024/07/01-Robert-A-MichaelRobert A. Michael Assumes Role as AbbVie Chief Executive ...

   news.abbvie.com › 2024/07/01-Robert-A-Michael

   • Cached

   1 day ago · NORTH CHICAGO, Ill., July 1, 2024 / PRNewswire / -- AbbVie (NYSE: ABBV) today announced that Robert A. Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today. As previously announced, Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company's inception ...

4. www.fiercepharma.com › pharma › amid-humirasAbbVie CEO telegraphs retirement and prepares to pass baton ...

   www.fiercepharma.com › pharma › amid-humiras

   • Cached

   Feb 20, 2024 · Robert Michael, AbbVie’s current president and chief operating officer, has been tapped by the company’s board of directors to take over Gonzalez’s CEO post on July 1, AbbVie said Tuesday....

5. www.pharmexec.com › view › robert-michael-abbvie-ceoRobert A. Michael Becomes AbbVie CEO - pharmexec.com

   www.pharmexec.com › view › robert-michael-abbvie-ceo

   • Cached

   13 hours ago · As previously announced, Michael assumed the role on July 1. Robert A. Michael has assumed the role of CEO at AbbVie. 1 He has replaced Richard A. Gonzalez, who stepped down from the role after serving in it since 2013. Michael will also join the board the directors. In a press release, Michael said, “It is an honor to step into the CEO role ...

6. news.abbvie.com › 2024/02/20-AbbVie-AnnouncesAbbVie Announces Appointment of Robert A. Michael as Chief ...

   news.abbvie.com › 2024/02/20-AbbVie-Announces

   • Cached

   Feb 20, 2024 · Robert A. Michael is president and chief operating officer of AbbVie. A member of AbbVie's Executive Leadership Team, Mr. Michael is responsible for global commercial operations, finance, corporate human resources, global operations, business development and corporate strategy for the company.

7. finance.yahoo.com › news › abbvie-announcesAbbVie Announces Appointment of Robert A. Michael as Chief ...

   finance.yahoo.com › news › abbvie-announces

   • Cached

   Feb 20, 2024 · AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously selected Robert A. Michael, AbbVie's current president and chief operating officer, to succeed Richard A....

8. People also ask

   How many employees does AbbVie have?

   • In that time, AbbVie has grown to more than 50,000 employees and serves patients in more than 175 countries with its portfolio of innovative medicines. Prior to AbbVie's separation from Abbott in January 2013, Mr. Gonzalez was a 30-year Abbott veteran. He served as president and chief operating officer of Abbott.

   AbbVie Announces Appointment of Robert A. Michael as Chief Executive

   finance.yahoo.com/news/abbvie-announces-appointment-robert-michael-140000197.html

   See all results for this question

   Does AbbVie approve elahere?

   • AbbVie announced that the U.S. Food and Drug Administration (FDA) granted full approval for Elahere for the treatment of FRα-positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal adult cancer patients treated with up to three prior therapies.

   AbbVie Reports First-Quarter 2024 Financial Results | AbbVie

   investors.abbvie.com/news-releases/news-release-details/abbvie-reports-first-quarter-2024-financial-results

   See all results for this question

   Will AbbVie acquire Landos Biopharma?

   • AbbVie and Landos Biopharma announced a definitive agreement under which AbbVie will acquire Landos, a clinical stage biopharmaceutical company focused on the development of novel, oral therapeutics for patients with autoimmune diseases.

   AbbVie Reports First-Quarter 2024 Financial Results | AbbVie

   investors.abbvie.com/news-releases/news-release-details/abbvie-reports-first-quarter-2024-financial-results

   See all results for this question

   What is AbbVie's diluted EPS guidance for 2024?

   • AbbVie is raising its adjusted diluted EPS guidance for the full year 2024 from $10.97 - $11.17 to $11.13 - $11.33, which includes an unfavorable impact of $0.08 per share related to acquired IPR&D and milestones expense incurred during the first quarter 2024.

   AbbVie Reports First-Quarter 2024 Financial Results | AbbVie

   investors.abbvie.com/news-releases/news-release-details/abbvie-reports-first-quarter-2024-financial-results

   See all results for this question

9. investors.abbvie.com › news-releases › news-releaseAbbVie Reports First-Quarter 2024 Financial Results | AbbVie

   investors.abbvie.com › news-releases › news-release

   • Cached

   Apr 26, 2024 · AbbVie announced that its board of directors unanimously selected Robert A. Michael, AbbVie 's current president and chief operating officer, to succeed Richard A. Gonzalez as the company's chief executive officer (CEO).